T-025

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameT-025
Drug Alias NameCLK inhibitors (Takeda Pharmaceutical)Cdc2-like kinase inhibitors (Chordia Therapeutics)Cdc2-like kinase inhibitors (Takeda Pharmaceutical)CLK inhibitors (Chordia Therapeutics)T-025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionClk dual-specificity kinase inhibitors
TargetsDual specificity protein kinase CLK
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChordia Therapeutics IncTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A